InhaleRx eyes big pharma deal and ponders product launch through SAS by Steve Jones March 18, 2025March 18, 2025 InhaleRx is considering making its inhaled THC medicine available through the Special Access Scheme (SAS) as […]
InhaleRx secures up to $38.5m in funding for clinical trial program by Martin Lane October 18, 2024February 25, 2025
